0001104659-19-003196.txt : 20190124
0001104659-19-003196.hdr.sgml : 20190124
20190124174536
ACCESSION NUMBER: 0001104659-19-003196
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190122
FILED AS OF DATE: 20190124
DATE AS OF CHANGE: 20190124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Souza Marcio
CENTRAL INDEX KEY: 0001707657
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 19540776
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
a4.xml
4
X0306
4
2019-01-22
0
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001707657
Souza Marcio
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
0
1
0
0
Chief Operating Officer
Common Stock
2019-01-22
4
A
0
1925
0
A
4667
I
By Spouse
Stock Option (Right to Buy)
33.02
2019-01-22
4
A
0
112500
0
A
2029-01-21
Common Stock
112500
112500
D
Stock Option (Right to Buy)
33.02
2019-01-22
4
A
0
25000
0
A
2029-01-21
Common Stock
25000
25000
D
Stock Option (Right to Buy)
33.02
2019-01-22
4
A
0
6825
0
A
2029-01-21
Common Stock
6825
6825
I
By Spouse
Restricted stock unit granted on January 22, 2019 that vests in four equal installments over four years, commencing on January 22, 2020.
This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.
/s/ Avraham S. Adler, attorney-in-fact
2019-01-24